Trial Profile
A Study Assessing the Immunologic Effect of Radium-223 in Patients With Metastatic Prostate Cancer
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 22 Jun 2018
Price :
$35
*
At a glance
- Drugs Radium 223 chloride (Primary)
- Indications Prostate cancer
- Focus Pharmacodynamics
- 22 Jun 2018 New trial record
- 05 Jun 2018 Results of survival and immune analysis of radium-223 from this study, presented at the 54th Annual Meeting of the American Society of Clinical Oncology.